Wang, Zhifa <br/><br/>
Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder.  [electronic resource] 

 -  Cardiovascular therapeutics  Dec 2018 
 - e12482 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1755-5922 
<br/><br/><label>Standard No.: </label>10.1111/1755-5922.12482  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Adenosine Triphosphate--metabolism<br/>Aminoimidazole Carboxamide--analogs & derivatives<br/>Animals<br/>Blood Glucose--drug effects<br/>Cardiopulmonary Bypass--adverse effects<br/>Creatine Kinase, MB Form--blood<br/>Disease Models, Animal<br/>Enzyme Activation<br/>Enzyme Activators--pharmacology<br/>GTPase-Activating Proteins--metabolism<br/>Glucose Metabolism Disorders--blood<br/>Glucose Transporter Type 4--metabolism<br/>Heart Diseases--enzymology<br/>Male<br/>Myocardium--enzymology<br/>Phosphorylation<br/>Rats, Sprague-Dawley<br/>Ribonucleotides--pharmacology<br/>Signal Transduction--drug effects<br/>Troponin I--blood